Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Eliem Therapeutics, Inc. (ELYM)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
   10-K8-K10-K8-K10-KS-1/A
Net income  -45.20.0-47.5-0.1-20.7-7.4
Change in working capital  7.0 5.5 1.2 
Other operating activities  0.9 5.9 5.4 
Cash from operations  -37.4 -36.1 -14.1 
   
Capital expenditures  0.0 0.0 0.0 
Purchases of short-term investments  88.0 115.0   
Other cash from investing  -53.5 -229.9 8.1 
Cash from investing  34.4 -115.0 8.1 
   
Issuance of common stock, net    0.1   
Other cash from financing    177.1 4.9 
Cash from financing  0.0 177.2 4.9 
   
Free cash flow  -37.4 -36.1 -14.1 
        Per share (diluted)  ($1.42) ($2.94) ($6.44) 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy